Oak Street Health Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Oak Street Health stock.
View analyst ratings for Oak Street Health or view top-rated stocks.

Wall Street analysts have given Oak Street Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Oak Street Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Oak Street Health is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for Oak Street Health.

Oak Street Health will be holding an earnings conference call on Tuesday, March 9th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Oak Street Health, Inc. (NYSE:OSH) issued its quarterly earnings results on Monday, November, 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.15). The business had revenue of $217.90 million for the quarter, compared to analysts' expectations of $213 million. The company's revenue for the quarter was up 56.6% on a year-over-year basis.
View Oak Street Health's earnings history.

12 analysts have issued 12-month price objectives for Oak Street Health's stock. Their forecasts range from $52.00 to $78.00. On average, they anticipate Oak Street Health's stock price to reach $66.40 in the next year. This suggests a possible upside of 26.7% from the stock's current price.
View analysts' price targets for Oak Street Health or view top-rated stocks among Wall Street analysts.

17 employees have rated Oak Street Health CEO Peter Botten on Glassdoor.com. Peter Botten has an approval rating of 71% among Oak Street Health's employees.

Some companies that are related to Oak Street Health include DCC (DCCPF), U.S. Physical Therapy (USPH), The Pennant Group (PNTG), CRH Medical (CRHM), Covalon Technologies (CVALF), Union Dental (UDHI), Accelera Innovations (ACNV) and Verisante Technology (VRSEF).
View all of OSH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Alibaba Group (BABA), Tesla (TSLA), Adobe (ADBE), NVIDIA (NVDA), Okta (OKTA), Zoom Video Communications (ZM), Autodesk (ADSK), The Boeing (BA), Lockheed Martin (LMT) and Micron Technology (MU).

(OSH) raised $250 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 15,600,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers.

Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH."

Oak Street Health's lock-up period expired on Tuesday, February 2nd. Oak Street Health had issued 15,625,000 shares in its initial public offering on August 6th. The total size of the offering was $328,125,000 based on an initial share price of $21.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.

Oak Street Health's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (1.59%), Price T Rowe Associates Inc. MD (0.61%), Wells Fargo & Company MN (0.37%), Brown Advisory Inc. (0.33%), Bloom Tree Partners LLC (0.30%) and JPMorgan Chase & Co. (0.23%). Company insiders that own Oak Street Health stock include General Atlantic Llc, Geoffrey M Price, Griffin Myers, Kim Keck, Michael T Pykosz, Robert Guenthner and Timothy M Cook.
View institutional ownership trends for Oak Street Health.

OSH stock was sold by a variety of institutional investors in the last quarter, including Bloom Tree Partners LLC, Healthcare of Ontario Pension Plan Trust Fund, Healthcare of Ontario Pension Plan Trust Fund, Inherent Group LP, Russell Investments Group Ltd., Squarepoint Ops LLC, Calamos Advisors LLC, and Next Century Growth Investors LLC. Company insiders that have sold Oak Street Health company stock in the last year include General Atlantic Llc, Geoffrey M Price, Griffin Myers, Michael T Pykosz, Robert Guenthner, and Timothy M Cook.
View insider buying and selling activity for Oak Street Health or view top insider-selling stocks.

OSH stock was purchased by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Nuveen Asset Management LLC, BlackRock Inc., Brown Advisory Inc., Orbimed Advisors LLC, Monashee Investment Management LLC, PFM Health Sciences LP, and Schroder Investment Management Group.
View insider buying and selling activity for Oak Street Health or or view top insider-buying stocks.

Shares of OSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OSH stock can currently be purchased for approximately $52.41.

Oak Street Health has a market capitalization of $12.62 billion.

Oak Street Health employs 2,300 workers across the globe.

The official website for Oak Street Health is www.oakstreethealth.com.

Oak Street Health is headquartered at 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603.

Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The company can be reached via phone at 312-733-9730 or via email at [email protected]